銅触媒下で行うクロスカップリング反応やC-H活性化反応を利用したセレン含有化合物群の一般合成法の開発

書誌事項

タイトル別名
  • Development of a General Synthetic Method for Organoselenium Compounds Utilizing Copper Catalyzed Cross Coupling and C-H Bond Activation
  • Review for award 銅触媒下で行うクロスカップリング反応やC-H活性化反応を利用したセレン含有化合物群の一般合成法の開発
  • Review for award ドウ ショクバイ カ デ オコナウ クロスカップリング ハンノウ ヤ C-H カッセイカ ハンノウ オ リヨウ シタ セレン ガンユウ カゴウブツグン ノ イッパン ゴウセイホウ ノ カイハツ

この論文をさがす

説明

<p>Organoselenium compounds have attracted significant interest because of their use as important reagents in organic syntheses and potential biological activities, necessitating the development of simple and general synthetic methods. This article reviews our studies to develop of copper-catalyzed C-Se bond formation reactions via cross coupling and C-H activation. A number of unsymmetrical and symmetrical diaryl selenides were synthesized via Se-arylation of diaryl diselenides or selenium powder with triarylbismuthanes under aerobic conditions, achieving moderate to excellent yields. When the reaction of triphenylbismuthane with elemental Se was monitored with gas chromatography, diphenyl diselenide and diphenyl selenide formation was confirmed. Subsequently, 1-pot 2-step reactions were performed under mild conditions to obtain 3-selanyl imidazo[1,2-a]pyridines from triarylbismuthanes and diimidazopyridyl diselenides, which were generated from imidazo[1,2-a]pyridines and Se powder, in good to excellent yields. It should be noted that all three aryl groups in the bismuth and both selanyl groups in the diaryl diselenide generated from the selenium source were transferred to the coupling products. Cu-catalyzed tandem cyclization of 2-(2-iodophenyl)imidazo[1,2-a]pyridines with selenium for the synthesis of benzo[b]selenophene-fused imidazo[1,2-a]pyridines is also described herein. The molecular structure of the tetracyclic compound features nearly coplanar rings, and the maximum absorption is red-shifted compared to those of imidazo[1,2-a]pyridine and benzoselenophene.</p>

収録刊行物

  • 薬学雑誌

    薬学雑誌 140 (9), 1101-1106, 2020-09-01

    公益社団法人 日本薬学会

参考文献 (19)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ